Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan-Feb;12(1):85-91.

Impact of the severity of end-stage liver disease in cardiac structure and function

Affiliations
  • PMID: 23293198
Free article

Impact of the severity of end-stage liver disease in cardiac structure and function

Odilson Marcos Silvestre et al. Ann Hepatol. 2013 Jan-Feb.
Free article

Abstract

Background: The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes.

Material and methods: 184 patients underwent a protocol providing data on the severity of ESLD and undergoing echocardiography to assess the diameters of the left atrium and right ventricle; the systolic and diastolic diameters of the left ventricle, interventricular septum, and posterior wall of the left ventricle; systolic pulmonary artery pressure; ejection fraction; and diastolic function. Severity of ESLD was assessed by the Model for End-Stage Liver Disease (MELD) score.

Results: Left-atrial diameter (r = 0.323; IC 95% 0.190-0.455; p < 0.001), left-ventricular diastolic diameter (r = 0.177; IC 95% 0.033-0.320; p = 0.01) and systolic pulmonary artery pressure (r = 0.185; IC 95% 0.036-0.335; p = 0.02) significantly correlated with MELD score. Patients with MELD ≥ 16 had significantly higher left-atrial diameter and systolic pulmonary artery pressure, compared with patients with MELD scores < 16 points.

Conclusions: Changes in cardiac structure and function correlate with the severity of ESLD.

PubMed Disclaimer

Comment in

  • Cardiac changes and liver disease.
    Song ZZ, Tang JL, Wang J, Hou CJ, Zhang F, Fan XM. Song ZZ, et al. Ann Hepatol. 2013 Mar-Apr;12(2):340. Ann Hepatol. 2013. PMID: 23396749 No abstract available.
  • Author's replay.
    Silvestre OM, Farias AQ. Silvestre OM, et al. Ann Hepatol. 2013 Mar-Apr;12(2):340. Ann Hepatol. 2013. PMID: 23745216 No abstract available.

Publication types

MeSH terms

LinkOut - more resources